Although technologies have advanced significantly since the first approval was given for a clinical trial of a gene therapy product in 1990, many challenges remain. 1 Among them is the need for fast, ...

A mAb downstream suite. The mAb downstream viral clearance is accomplished by a combination of orthogonal or complementary approaches including filtration, chromatography, and chemical inactivation.

Biopharmaceutical downstream processing requires precise control of multiple unit operations—from chromatography and filtration to viral inactivation—to ensure product quality and therapeutic efficacy ...

Making a therapeutic that contains biological components is just the start of creating a medicine. Then, biopharmaceutical companies must capture that drug and ensure that it’s free of contamination.

Milestone Marks Completion of First Phase of Two-Part Myford Facility Expansion; First Customer Project to Begin in New Downstream Processing Suite in Coming Month TUSTIN, Calif., Jan. 10, 2022 (GLOBE ...

Recombinant baculoviruses (rBVs) are widely used as vectors for the production of recombinant proteins in insect cells. More recently, these viral vectors have been gaining increasing attention due to ...

Osmolality is a well-established parameter for upstream bioprocessing, formulation, analytical development and QC applications throughout the manufacturing of biological drugs. A recent publication ...

The Downstream Processing Market is entering a high-stakes expansion phase driven by surging biopharmaceutical production, intensified demand for monoclonal antibodies, and rapid scale-up of cell and ...